Weighted Average Number of Shares Outstanding, Basic of SUTRO BIOPHARMA, INC. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
SUTRO BIOPHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • SUTRO BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 84,869,864, a 3.4% increase year-over-year.
  • SUTRO BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 76,829,198, a 28% increase from 2023.
  • SUTRO BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60,163,542, a 19% increase from 2022.
  • SUTRO BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 50,739,185, a 10% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

SUTRO BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 84,869,864 +2,826,193 +3.4% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 84,580,125 +3,355,497 +4.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 83,106,013 +21,648,220 +35% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 76,829,198 +16,665,656 +28% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 82,043,671 +21,444,646 +35% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 81,224,628 +20,885,153 +35% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 61,457,793 +2,734,361 +4.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 60,163,542 +9,424,357 +19% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 60,599,025 +8,253,293 +16% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 60,339,475 +13,382,279 +28% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 58,723,432 +12,223,830 +26% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 50,739,185 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q3 2022 52,345,732 +6,183,188 +13% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 46,957,196 +841,021 +1.8% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 46,499,602 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 46,162,544 +9,275,278 +25% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 46,116,175 +16,215,262 +54% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q3 2020 36,887,266 +13,940,277 +61% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 29,900,913 +6,974,523 +30% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q3 2019 22,946,989 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 22,926,390 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2

SUTRO BIOPHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 76,829,198 +16,665,656 +28% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 60,163,542 +9,424,357 +19% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 50,739,185 +4,620,096 +10% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
2021 46,119,089 +13,545,620 +42% 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024 2023 FY
2020 32,573,469 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.